An in-vivo study of the integrity of the nigrostriatal pathways in drug-naive Parkinson's disease patients using [11C]PE2I PET and neuromelanin-Magnetic Resonance Imaging

被引:0
|
作者
Pagano, G.
Wilson, H.
de Natale, E.
Niccolini, F.
Polychronis, S.
Yousaf, T.
Gunn, R.
Rabiner, E.
Mehta, M.
Politis, M.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1596
引用
收藏
页码:S704 / S704
页数:1
相关论文
共 33 条
  • [21] Evaluation of Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's Disease: An in vivo [11C]BU99008 PET study
    Wilson, H.
    Dervenoulas, G.
    Pagano, G.
    Tyacke, R.
    Myers, J.
    Gunn, R.
    Rabiner, E.
    Nutt, D.
    Politis, M.
    MOVEMENT DISORDERS, 2019, 34 : S835 - S836
  • [22] Evaluation of Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo [11C] BU99008 PET study
    Wilson, H.
    Dervenoulas, G.
    Pagano, G.
    Tyacke, R.
    Myers, J.
    Gunn, R.
    Rabiner, E.
    Nutt, D. J.
    Politis, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 1005 - 1005
  • [23] Measuring synaptic density and the dopamine transporter in Parkinson's disease: a PET imaging study with 11C-UCB-J and 18F-FE-PE2I
    Matuskey, David
    Tinaz, Sule
    Dias, Mark
    Naganawa, Mika
    Gallezot, Jean-Dominique
    Holmes, Sophie
    Henry, Shannan
    Koohsari, Sheida
    Ropchan, Jim
    Comley, Robert A.
    Nabulsi, Nabeel
    Huang, Yiyun H.
    Carson, Richard E.
    Finnema, Sjoerd J.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (1_SUPPL): : 161 - 162
  • [24] Longitudinal comparison of 11C-PE2I and 18F-DOPA pet for assessing severity and rate of disease progression in patients with Parkinson's disease
    Li, W.
    Lao-Kaim, N. P.
    Roussakis, A.
    Martin-Bastida, A.
    Loane, C.
    Valle-Guzman, N.
    Kefalopoulou, Z.
    Politis, M.
    Foltynie, T.
    Barker, R. A.
    Piccini, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 128 - 128
  • [25] Longitudinal comparison of 11C-PE2I and 18F-DOPA PET for assessing severity and rate of disease progression in patients with Parkinson's disease
    Li, W.
    Lao-Kaim, N.
    Roussakis, A. -A.
    Martin-Bastida, A.
    Loane, C.
    Valle-Guzman, N.
    Kefalopoulou, Z.
    Politis, M.
    Foltynie, T.
    Barker, R.
    Piccini, P.
    MOVEMENT DISORDERS, 2017, 32
  • [26] The role of Synaptic vesicle protein 2A (SV2A) in patients with Parkinson's disease dementia and Dementia with Lewy bodies: An in vivo [11C]UCB-J PET study
    Wilson, H.
    Dervenoulas, G.
    Pagano, G.
    Chandra, A.
    Niccolini, F.
    Esposito, M.
    Gunn, R.
    Ricciardi, L.
    Rabiner, E.
    Aarsland, D.
    Politis, M.
    MOVEMENT DISORDERS, 2019, 34 : S836 - S836
  • [27] The role of synaptic vesicle protein 2A (SV2A) in patients with Parkinson's disease dementia and dementia with Lewy bodies: an in vivo [11C]UCB-J PET study
    Wilson, H.
    Dervenoulas, G.
    Pagano, G.
    Chandra, A.
    Niccolini, F.
    Esposito, M.
    Gunn, R.
    Ricciardi, L.
    Rabiner, E.
    Aarsland, D.
    Politis, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 317 - 317
  • [28] Variations in adenosine A2A receptors following anti-Parkinsonian therapy in drug naive Parkinson's disease using 11C-TMSX PET
    Hishina, M.
    Ishii, K.
    Kitamura, S.
    Kimura, Y.
    Naganawa, M.
    Hashimoto, M.
    Suzuki, M.
    Oda, K.
    Hamamoto, M.
    Kobayashi, S.
    Katayama, Y.
    Ishiwata, K.
    MOVEMENT DISORDERS, 2008, 23 (01) : S68 - S68
  • [29] In vivo evaluation of adenosine a2A receptor availability in Parkinson's disease patients with and without levodopa induced dyskinesias studied with [11C]SCH442416 PET
    Ramlackhansingh, A. B.
    Bose, S. K.
    Ahmed, I.
    Turkheimer, F. E.
    Pavese, N.
    Brooks, D. J.
    MOVEMENT DISORDERS, 2010, 25 (07) : S420 - S420
  • [30] Quantitation of adenosine A2A receptors availability in Parkinson's Disease patients with and without dyskinesias with [11C]SCH442416 PET using spectral analysis
    Bose, Subrata K.
    Ramlackhansingh, Anil F.
    Ahmed, Imtiaz
    Pavese, Nicola
    Brooks, David J.
    Turkheimer, Federico E.
    NEUROIMAGE, 2010, 52 : S216 - S217